News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Biotech Syndax Pharmaceuticals Inc. Sets Terms For $60 Million IPO


6/6/2014 6:58:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Syndax Pharmaceuticals, a late-stage biotech developing a novel therapy for resistant breast cancer, announced terms for its IPO on Thursday. The Waltham, MA-based company plans to raise $60 million by offering 4.3 million shares at a price range of $13 to $15. At the midpoint of the proposed range, it would command a fully diluted market value of $179 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES